Fulgent Genetics (FLGT) Cash from Discontinued Operations (2015 - 2016)

Fulgent Genetics (FLGT) posted Cash from Discontinued Operations of 14000.0 for Q2 2016, up 17.65% sequentially from 17000.0 in Q1 2016.

Fulgent Genetics (FLGT) Cash from Discontinued Operations (2015 - 2016) Analysis & Trends

Fulgent Genetics has reported Cash from Discontinued Operations for 2 years, with the latest figure at 14000.0 in Q2 2016.

Quarterly Cash from Discontinued Operations changed N/A year-over-year to 14000.0 in Q2 2016, while the trailing twelve-month figure through Dec 2016 was 31000.0 (changed N/A YoY) and the FY2016 annual result came in at 31000.0, up 98.96% from the prior year.
Cash from Discontinued Operations climbed to 14000.0 in Q2 2016 per FLGT's latest filing, from 17000.0 in the prior quarter.
Over five years, Cash from Discontinued Operations peaked at 14000.0 in Q2 2016 and troughed at 916000.0 in Q4 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Discont. Ops (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn	-
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn	-
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn	-
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn	-
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn	-
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn	-
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn	-
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn	-
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn	-
10	Fulgent Genetics	518.37 Mn	261.34 Mn	25.68 Mn	-

Download Data